A lot is brewing at Iantrek! Keep scrolling down to discover the latest developments at the forefront of our micro-interventional glaucoma technology. https://iantrekmed.com/newsletter/
Iantrek News
What's next in microinterventional ophthalmic surgery

IANTREK TECHNOLOGY AT ARVO
News | April 21, 2023
Congratulations to Dr. Carol Toris and her team at the University of Nebraska Medical Center on their groundbreaking study on the outflow facility of single vs dual wall canalotomy. Their […]
Celebrating Our Top 100 Power Listers
News | April 18, 2023
We are thrilled to announce that five of our very own clinicians and innovators at Iantrek have made it on the highly acclaimed Ophthalmologist Power List for 2023. Dr. Ike […]
Iantrek founder, Dr. Ianchulev unveils T-Rex technology at G360
News | March 27, 2023
At the annual 2023 Glaucoma Research Foundation meeting, Dr, Ianchulev, Iantrek’s founder and Professor of Ophthalmology at New York Eye and Ear of Mount Sinai, gave the New Horizons Innovation […]
Iantrek Innovations at the Glaucoma 360 Conference
News | February 8, 2023
At this year’s Glaucoma360 conference in San Francisco, world-renowned glaucoma specialists, scientists and industry gathered to discuss the latest advances in the diagnosis and treatment of glaucoma.
Iantrek’s technology in the spotlight
News | February 8, 2023
Dr. Ike Ahmed at the Moran Eye Institute reviews latest MIGS innovations and discusses Iantrek’s next generation micro-interventional technology for supraciliary bio-stenting. Read about the latest clinical experience with this advanced, first-in-class MIGS technology and the unique approach for hardware-free stenting of the suprachoroidal outflow pathway. Discussed are the 12 month clinical outcomes from the BJO publication.
12-month clinical results of a novel micro-interventional bio-stenting procedure published in the British Journal of Ophthalmology
News | January 23, 2023
Iantrek announces publication in the prestigious peer-review journal British Journal of Ophthalmology the results of a first-of-a-kind clinical investigation of supraciliary stenting – a novel MIGS approach to the suprachoroidal space using 100% biologic, hardware-free micro-interventional technology.
Glaucoma Surgical Market Fastest Growing Ophthalmic Segment through 2026
News | November 10, 2022
According to Market Scope, the Glaucoma Surgical market segment is expected to be the highest growing market segment in ophthalmology through 2026, growing at a CAGR of nearly 19%. This […]
Iantrek unveils breakthrough
technology at AAO
News | November 10, 2022
The Iantrek team had a very successful AAO meeting in Chicago this year, where two presentations of our breakthrough technologies received exceptional accolades and were highlighted in the AAO media. […]
Iantrek Quarterly – Fall Issue
News | November 2, 2022
Welcome to the inaugural issue of Iantrek Quarterly, where you can find out about the latest happenings at the forefront of micro-interventional glaucoma technology. https://iantrekmed.com/newsletter/
No more posts to load!
